Nova’s influenza model accounts for the interplay between a viral infection and vaccination. It describes the key pathways and biomarkers influencing vaccine efficacy, including antigenic drift, strain, immunogenicity, immunosenescence and timing of vaccination.


  1. Model description (Influenza)
    1. Drugs that can be tested
    2. Populations of interest
    3. Possible clinical endpoints
    4. Biological submodels
  2. Early insights to optimize your trial design

    1. Vaccination
    2. Patient selection
    3. Vaccine strain


Get your questions answered by downloading the free pdf and learn more about your therapeutic area of interest!

  • Your information will be processed by Nova to send you the content requested. For more information about our processing or to exercise your GDPR rights, see our Privacy Policy
  • This field is for validation purposes and should be left unchanged.